Correlation of PD-L1 expression and tumour outcomes in NSCLC patients

Date 20 November 2015
Event ESMO Symposium on Immuno-Oncology 2015
Session PD-1/PD-L1 axis blockade, results to date
Topics Cancer Immunology and Immunotherapy
Lung and other Thoracic Tumours
Presenter Gregory Lubiniecki
Authors G.M. Lubiniecki
  • Mrl, Clinical Research, MSD Corp., 19454 - North Wales/US